Add to Favorites Newsroom RSS Share
fb-shareYale Cancer Center
New Haven, CT USA

Our News on Newswise

Newswise: Dr.TaraSanft.jpg

Sanft named Chief Patient Experience Officer at Smilow Cancer Hospital

Tara Sanft, M.D., associate professor of Medicine (Medical Oncology) and Director of the Smilow Cancer Hospital (SCH) Survivorship Clinic, has been appointed the inaugural Chief Patient Experience Officer at Yale Cancer Center (YCC) and SCH at Yale...
10-Jan-2020 3:35 PM EST Add to Favorites

Newswise: Dr.SarahMougalian.jpg

Mougalian appointed Deputy Chief Ambulatory Officer at Smilow Cancer Hospital

Sarah Mougalian, M.D., assistant professor of Medicine (Medical Oncology) has been named the inaugural Deputy Chief Ambulatory Officer at Smilow Cancer Hospital (SCH) at Yale New Haven Hospital.
10-Jan-2020 3:30 PM EST Add to Favorites

Newswise: Smilowpic2.jpg

Yale Cancer Center launches Center for Community Engagement and Health Equity

Yale Cancer Center (YCC) announces the launch of the Center for Community Engagement and Health Equity (CEHE). Building on YCC’s longstanding commitment to high-quality, expert, and patient-centered cancer care, screening, and prevention across...
26-Dec-2019 11:50 AM EST Add to Favorites

Newswise: DanielPetrylakMD.jpg

Backed by Yale Cancer Center research, FDA approves new drug for advanced bladder cancer

The U.S. Food & Drug Administration (FDA) granted accelerated approval to the drug enfortumab vedotin (EV) to treat adult patients with advanced urothelial or bladder cancer.
19-Dec-2019 9:45 AM EST Add to Favorites

Newswise: NamrataChandhokaMD.jpg

Yale Cancer Center researchers investigate inducing “synthetic lethality” in two blood and bone cancers

In a clinical trial led by Yale Cancer Center (YCC) and Smilow Cancer Hospital, researchers aim to exploit DNA mutations in the treatment of two blood and bone marrow cancers, a different tacit than the more traditional approach of blunting or...
10-Dec-2019 10:55 AM EST Add to Favorites

Newswise: ScottHuntingtonMDMPH.jpg

Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients

New findings by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers show that as the use of the drug ibrutinib climbs in patients with chronic lymphocytic leukemia (CLL), so do the rates of patients who stop taking the drug.
9-Dec-2019 10:50 AM EST Add to Favorites

Newswise: RongWangPhD.jpg

Yale Cancer Center study highlights challenges for care of AML patients during initial chemotherapy

A new study by Yale Cancer Center (YCC) researchers shows understanding treatment patterns for patients with acute myeloid leukemia (AML) is vital to develop strategies to improve outcomes.
9-Dec-2019 11:20 AM EST Add to Favorites

Newswise: AmerZeidanMBBS.jpg

Yale Cancer Center researchers show promising new treatment for patients with myelodysplastic syndromes

A new study by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.
9-Dec-2019 11:05 AM EST Add to Favorites


see all news

Our Experts on Newswise

Newswise: MichaelGirardiMDPhD.jpg

Five Ways to Lower Your Skin Cancer Risk

Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT

Yale Expert Discusses Treatment for Endometrial Cancer

Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT

Expert Speaks on Utilizing Information Technology to Address Oral Chemotherapy Challenges

Utilizing Information Technology to Address Oral Chemotherapy Challenges
26-Mar-2018 2:05 PM EDT

Newswise: prasanna.jpg

Yale Expert Available to Speak on Medical Marijuana for Children with Cancer

12-Mar-2018 3:05 PM EDT

Newswise: Capture.PNG

Overcoming Resistance to Immunotherapy

For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT

Daniel P. Petrylak, MD, on Urothelial Carcinoma: Results of the RANGE Trial

6-Oct-2017 3:05 PM EDT

Newswise: LiepingChen.JPG

Yale Expert Wins Prestigious 2017 Warren Alpert Prize

6-Oct-2017 2:05 PM EDT

Newswise: CharlesFuchsMDMPHcasual.jpg

Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer

22-Sep-2017 4:30 PM EDT

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 40 years, Yale Cancer Center is one of only 45 Centers in the nation.

Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital at Yale-New Haven. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.

Experts

  • Anees Chagpar

    Associate Professor; Director, Assistant Director

    Keywords:
    Breast Cancer, Yale Cancer Center, breast surgeon, hereditary breast and ovarian cancer syndrome breast cancer, Breast Neoplasms, Global affairs, Healthcare
     
     
  • Charles Fuchs

    Professor; Director; Physician-in-Chief

    Keywords:
    Colorectal Cancer, Gastrointestinal Cancer, Yale Cancer Center, Cancer epidemiology, Cancer Prevention and Control
     
     
  • Roy Herbst

    Ensign Professor; Professor; Chief

    Keywords:
    Lung Cancer, Nsclc, Clinical Trials For Cancer, Yale Cancer Center, Immunotherapy
     
     

Contacts

Anne Doerr
Director of Media Relations

anne.doerr@yale.edu

203-737-2629

Renee Gaudette
Director of Marketing & Public Affairs

renee.gaudette@yale.edu

203-671-8156

Scott Gettinger
Associate Professor of Medicine

scott.gettinger@yale.edu

Emily Montemerlo
Marketing Coordinator

emily.fenton@yale.edu

203-785-4343

Twitter twitter-icon

Chat now!
0.75674